Powering genomics with results you can see
In order to sequence with confidence, you need to trust your results. Our sequencers have a proven track record of providing highly accurate data with a complete view of genomic variation — even in hard-to-reach regions of the genome.
Explore how researchers from around the world use PacBio sequencing to fuel discovery.
Don’t take our word for it. Take theirs.
Shaping the future
Partnering to seek insights on rare disease
Children’s Mercy Kansas City
Experts at Children’s Mercy turn to long-read whole genome sequencing to move beyond microarrays and exomes and provide explanations for the families of children with complex rare disease.
“What long-read sequencing gives us is the internal nucleotide structure. That’s just unprecendented, and it’s extremely valuable.”
— Meredith Course, PhD, Research Fellow University of Washington
SHAPING THE FUTURE
Helping pinpoint a cause of neurological disease
University of Washington
ALS, or Lou Gehrig’s disease, affects at least 16,000 Americans at any given time. Luckily, ALS research has made great strides in recent years.
See how the University of Washington used HiFi sequencing to uncover a key finding about ALS and the human genome.
See more customer stories
DIVING DEEP INTO MARINE LIFE
Scientists use SMRT sequencing to explore the genomes of a wide variety of marine species and ecosystems.
SEQUENCING HISTORIC BACTERIA WITH EASE
PacBio sequencing helped establish the UK’s NCTC, a unique collection of more than 5,000 expertly preserved and authenticated bacterial cultures.
Protein discovery
Scientists at Second Generation teamed up with PacBio to explore how long-read sequencing could supplement a short-read-based pipeline for protein discovery.
Pioneering a pangenome
DuPont Pioneer uses PacBio technology to reveal the genetic basis for traits of interest in crops such as maize, soybean, alfafa, canola, wheat, rice, and more.
Advancing UK genomics
SMRT sequencing and HiFi reads have increased throughput and reduced costs for the Earlham Institute.